Market Research Blog – Page 365 – New Product Development

Whole Genome Amplification Industry to Surpass USD 6.5 Million by 2034 at a 8.1% of CAGR, Driven by Rising Demand for Genetic Data Collection and Research Advancements

Whole Genome Amplification Market — Whole Genome Amplification Industry

The global whole genome amplification (WGA) market is set for robust growth, with its valuation expected to increase from USD 2.9 million in 2024 to over USD 6.5 million by 2034, at a CAGR of 8.1% during the forecast period. This surge is driven by the rising demand for comprehensive genetic data collection and mapping of the human genome.

Whole genome amplification techniques have gained significant attention as researchers and healthcare providers increasingly focus on personalized medicine, genetic diagnostics, and the identification of novel biomarkers. The method of whole-cell genome amplification is becoming a pivotal tool for applications in oncology, genetic research, and developmental biology.

Market expansion is also supported by growing awareness and educational initiatives highlighting the utility and benefits of WGA technology. These efforts are fostering its adoption across research institutions, biotechnology firms, and healthcare settings, creating a conducive environment for market growth.

Grab Your Complete Report Instantly – https://www.futuremarketinsights.com/reports/whole-genome-amplification-market

Key Takeaways:

Market Growth: The WGA market is projected to grow from USD 2.9 million in 2024 to USD 6.5 million by 2034, at a CAGR of 8.1%.
Rising Demand: Increasing focus on genetic data collection and genome mapping is a key driver of demand for WGA technology.
Applications in Research: WGA plays a critical role in oncology, genetic diagnostics, and personalized medicine, contributing to its widespread adoption.
Awareness Initiatives: Efforts to educate and inform stakeholders about the advantages of WGA are unlocking new growth opportunities.

The whole genome amplification market is poised to make a substantial impact on advancing genetic research, paving the way for breakthroughs in healthcare and biotechnology.

Growth Drivers

Increasing Demand for Genetic Data: The rising need for genetic data collection to identify and map genes in the human genome is driving the demand for whole genome amplification techniques.
Awareness and Initiatives: There is a growing awareness of WGA methods, supported by initiatives aimed at educating the scientific community about their benefits, which is expected to create lucrative opportunities in the market.
Government Support and Funding: Increased government backing for genomic research and initiatives aimed at enhancing healthcare infrastructure are contributing to market growth.
Technological Advancements: Innovations in WGA techniques are improving reliability and efficiency, making these methods more appealing for various applications in genomics and molecular diagnostics.

Applications

Whole genome amplification is increasingly used in various fields, including:

Genomic Research: For mapping and identifying genes.
Disease Diagnosis: Enhancing the accuracy of genetic testing.
Agricultural and Veterinary Applications: Improving genetic analysis in crops and livestock.

Regional Insights

The market is expected to see significant growth in regions such as North America, where a strong focus on research and development exists.
Asia-Pacific, particularly countries like India and China, is projected to experience rapid growth due to increasing investments in healthcare and genomics research.

Competition Outlook

The whole genome amplification market is poised to experience notable growth in the near future, owing to several factors. One of the main aspects of the dynamic growth is the increasing number of collaborations and partnerships between operating firms, leading to heightened market competition.

The demand for whole genome amplification is anticipated to develop due to the proliferation of product portfolios and strategic initiatives such as mergers and acquisitions, licensing, and partnerships. Such major mergers and acquisitions have further fuelled the growth of the market, contributing to the comprehensive expansion.

For instance

In April 2024, Takara Bio USA pitched the Shasta Single-Cell System, an automated, high-throughput NGS solution for oncology research, enabling novel biomarker discovery and saving time and costs for researchers.
In March 2024, BioSkryb Genomics launched ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core Kits, utilizing primary template-directed amplification for high-resolution single-cell DNA insights.

Leading Whole Genome Amplification Brands

GE Healthcare
Sygnis AG
Illumina, Inc.
Merck KGaA
Thermo Fisher Scientific Inc.
Eurofins Scientific
Agilent Technologies, Inc.
Oxford Nanopore Technologies
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc.

Key Segments of Market Report

By Product Type:

As per product type, the industry has been segmented into single-cell WGA kits, complete WGA kits, WGA re-amplification kits, WGA and chip DNA kits, and others.

By Application:

The segment is branched into applications for drug discovery and development, disease diagnosis, agriculture, veterinary research, forensics, and others.

By End User:

Pharma and biotech companies, hospitals and clinics, contract research organizations, research and academic institutes, and others mainly utilize the sector.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Magnetic Flow Meter Market to Surpass USD 5 Billion by 2032 Amid Rising Usage in Water and Wastewater Treatment Plants | Report by Future Market Insights, Inc.

The global magnetic flow meter market value is set to increase from USD 2.6 billion in 2022 to USD 5 billion by 2032. Overall magnetic flow meter sales in the global market will rise at 6.6% CAGR through 2032.

Water and wastewater treatment will remain the top-revenue generation application for the market. This is due to rising adoption of magnetic flow meters across water and wastewater treatment plants. The target segment will exhibit a CAGR of 6.0% through 2032.

Devices that measure fluid flow are known as magnetic flow meters. These devices have gained wider popularity across various industries. They allow end users to measure conductive fluid flow rates.Rising usage of magnetic flow meters in a variety of industries, including pulp & paper, chemical, food & beverage, and water & wastewater will boost the global market.

Growing need for accurate & dependable flow measurement devices will trigger magmeter sales. Thanks to their high levels of measurement accuracy and dependability, magnetic flow meters are becoming ideal for process control applications across a variety of industries.

Rising demand for freshwater coupled with increasing number of water & wastewater treatment plants will stimulate market expansion.Implementation of stringent regulations is another key factor that will fuel magnetic flow meter demand. Governments across the world are introducing new regulations and standards to lower pollution levels.As a result, accurate measurement and monitoring of fluid flow are necessary for a variety of applications, such as the handling of industrial waste.

Key Takeaways from the Magnetic Flow Meter Market Report:

Global sales of magnetic flow meters will surge at 6.6% CAGR during the projection period.
By product type, demand for in-line magnetic flow meters is set to increase at 6.3% CAGR.
Based on application, water & wastewater treatment segment will thrive at 6% CAGR through 2032.
The United States magnetic flow meter market will reach a valuation of US$ 788.8 million by 2032.
China magnetic flow meter industry is forecast to exhibit a CAGR of 8.1% through 2032.
Demand for magnetic flow meters in Korea will surge at 7.1% CAGR through 2032.
The magnetic flow meter market size in Japan will reach around US$ 776.0 million by 2032.

“Growing adoption of magnetic flow meters across various industries due to their attractive features such as cost-effectiveness and higher accuracy and reliability will boost the market.” Says a Future Market Insights analyst.

Who is Winning?

Honeywell International Inc., ABB Ltd, Siemens AG, Endress+Hauser AG, Emerson Electric Corporation, General Electric, Azbil Corporation, OMEGA Engineering, Inc., KROHNE Messtechnik GmbH, and Yokogawa Electric Corporation are key manufacturers of magnetic flow meters profiled in the report.

These leading players are aiming at launching new products, forming alliances and collaborations, and adopting merger & acquisition strategy to solidify their positions. For instance,

In December 2019, Emerson Electric Co launched Rosemount 8782 MS Slurry Sensor. It is intended for high noise and slurry applications in mining as well as the pulp and paper industry.
In May 2022, Aspen Tech completed its transaction with Emerson Electric Co. This includes the addition of Emerson’s OSI and GSS (Geological Simulation Software) businesses to AspenTech.

Global Magnetic Flow Meter Market Segmentation

By Product Type:

In-line magnetic flowmeter
Insertion Magnetic Flowmeter
Low magnetic Flowmeter

By Components:

Magnetic Coil
Transmitter
Sensing Electrode
Non Magnetic Flow Tube

By Technology:

Hart
Profibus
Modbus
Fieldbus

By Application:

Water and wastewater treatment
Chemicals
Oil And Gas
Turf and landscape
Pharmaceutical
Agriculture
Metal & Mining

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Orthokeratology Industry to Reach USD 659.1 Million by 2034, Growing at a CAGR of 4.8%

The global orthokeratology market is poised for steady growth, with its valuation expected to rise from USD 412.4 million in 2024 to USD 659.1 million by 2034, reflecting a CAGR of 4.8% over the forecast period.

Orthokeratology, a non-surgical vision correction method using specially designed gas-permeable contact lenses, is gaining traction as an effective treatment for conditions like myopia, hyperopia, and astigmatism. The increasing prevalence of myopia, particularly among children and young adults, is driving demand for orthokeratology as a safe and reversible alternative to corrective surgeries.

The market is also benefiting from heightened awareness of eye health and advancements in lens design and material technology, which enhance patient comfort and efficacy. Growing adoption of orthokeratology in emerging markets, coupled with supportive healthcare initiatives, is expected to further fuel market expansion.

Get the Comprehensive Full Report Now – https://www.futuremarketinsights.com/reports/orthokeratology-market

Key Takeaways:

Market Growth: The orthokeratology market is projected to grow from $412.4 million in 2024 to $659.1 million by 2034, at a CAGR of 4.8%.
Rising Myopia Cases: The increasing prevalence of myopia, particularly among younger demographics, is a key driver of market demand.
Technological Advancements: Innovations in lens design and material technology are enhancing the safety, comfort, and efficacy of orthokeratology solutions.
Emerging Market Opportunities: Expanding adoption in developing regions is contributing to the market’s growth trajectory.

The orthokeratology market’s progression underscores its importance as a non-invasive solution for vision correction, offering improved quality of life for individuals across age groups.

Growth Drivers

Increasing Prevalence of Myopia: The rising incidence of myopia, particularly among children and young adults, is driving demand for orthokeratology solutions that provide non-surgical vision correction.
Technological Advancements: Innovations in lens design and materials are enhancing the comfort and effectiveness of orthokeratology lenses, making them more appealing to users.
Awareness and Education: Growing awareness about the benefits of orthokeratology for managing refractive errors is encouraging more patients to seek these options.
Healthcare Infrastructure: Improved access to eye care services, particularly in developing regions, is facilitating the adoption of orthokeratology treatments.

Regional Insights

United States: The market in the U.S. is expected to grow at a CAGR of 5.8%, driven by established healthcare systems and high awareness levels regarding eye health.
India: Projected to experience significant growth at a CAGR of 9.23%, reflecting increasing healthcare investments and a rising population seeking vision correction solutions.
Taiwan and Germany: Both regions are also expected to see steady growth, with CAGRs of 7.1% and 4.2%, respectively.

Competitive Landscape

The orthokeratology market is competitive, with numerous significant competitors vying for market share and distinction. Leading companies in the industry, like Bausch + Lomb, Euclid Systems Corporation, and Paragon Vision Sciences, are renowned for their technological acumen and provide cutting-edge ortho-k solutions that meet the changing needs of consumers and practitioners. These businesses frequently carry out intensive R&D to create cutting-edge lens designs, materials, and production processes, fostering a vibrant and forward-thinking marketplace.

Recent Developments

In May 2023, Menicon Co. Ltd., launched orthokeratology lenses “Menicon Z Night” in China. The product is popular in Southeast Asia, Australia, and Europe.
In January 2023, CooperVision Specialty EyeCare announced the introduction of VisavyTM, a groundbreaking digital fitting tool pronounced by Vee-SAH-vee, at the 2023 Global Specialty Lens Symposium (GSLS). Topography-guided algorithms aid Paragon CRT® orthokeratology contact lens design and selection in the user-friendly web-based fitting program. This helps with myopia control.

Key Players in the Orthokeratology Market

Paragon Vision Sciences
Bausch + Lomb
Euclid Systems Corporation
GP Specialists
Art Optical Contact Lens, Inc.
Menicon Co., Ltd.
CooperVision
Visionary Optics, LLC
E&E Optics
Brighten Optix

Orthokeratology Market Segmentation

Product Type:

Day-time Ortho-K Lenses
Overnight Ortho-K Lenses

By Application:

Myopia
Presbyopia
Hypermetropia
Astigmatism

By End User:

Hospitals
Optometry Clinics
Ophthalmology Clinics
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)
Japan

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Meningococcal Vaccine Industry to Reach USD 9014 Million by 2034 at a 8.6% of CAGR, Driven by Rising Incidences of Meningitis and Vaccination Awareness

The global meningococcal vaccine market is set to experience remarkable growth, with its valuation expected to rise from USD 3.95 billion in 2024 to an impressive USD 9.01 billion by 2034, reflecting a robust CAGR of 8.6% during the forecast period, according to industry analysis.

The surge in market growth is largely attributed to the increasing prevalence of meningitis worldwide. In 2019, there were approximately 2.51 million cases of meningitis globally, with 1.28 million cases reported in children under five years old. The severity and fatality associated with the disease have driven heightened public awareness and increased vaccination efforts, particularly in regions with well-established healthcare systems, including the United States, the United Kingdom, India, and China.

Meningococcal vaccines have become a cornerstone in preventing the disease and its complications. Governments and healthcare organizations worldwide are implementing immunization programs and awareness campaigns to encourage vaccination, thereby contributing to the market’s expansion. Technological advancements in vaccine development and production are also playing a significant role in addressing unmet needs and ensuring wider accessibility.

Access the Full Report – https://www.futuremarketinsights.com/reports/meningococcal-vaccines-market

Key Takeaways:

Market Growth: The meningococcal vaccine market is projected to grow from $3.95 billion in 2024 to $9.01 billion by 2034, at a CAGR of 8.6%.
Global Disease Burden: In 2019, meningitis affected 2.51 million people globally, with children under five years constituting a significant proportion of cases.
Vaccination Trends: Countries with robust healthcare infrastructure are leading in vaccination adoption due to heightened awareness and preventive healthcare initiatives.
Technological Advances: Innovations in vaccine development are enhancing efficiency and accessibility, supporting broader immunization efforts.

The meningococcal vaccine market is poised for strong growth, reflecting its critical role in combating a life-threatening disease and safeguarding public health on a global scale.

Growth Drivers

Rising Incidence of Meningitis: In 2019, approximately 2.51 million cases of meningitis were reported worldwide, with a significant portion affecting children under five years old. This alarming statistic has heightened awareness and demand for vaccination.
Increased Public Awareness: Concerns about the fatality associated with meningococcal disease are prompting more individuals and families to seek vaccination.
Government Initiatives: Many countries are incorporating meningococcal vaccines into their national immunization schedules, targeting not only infants and young children but also adolescents and college students.
Technological Advancements: The development of new and improved vaccines, including conjugate and multivalent vaccines, is enhancing the effectiveness of immunization efforts.

Regional Insights

United States: The U.S. is expected to see substantial growth due to government mandates for vaccination in schools and colleges, ensuring high vaccination coverage.
United Kingdom: The UK is projected to exhibit a CAGR of 9.8%, driven by its robust national immunization program that includes meningococcal vaccines.
China: With a projected CAGR of 9.5%, China’s growth is supported by government investments in healthcare infrastructure and public awareness campaigns about meningococcal disease.

Competition Outlook

The competitive landscape of the global meningococcal vaccine market is primarily driven by innovations in vaccine formulations. The consumer base of the company in the industry totally depends on the efficiency, cost, and safety profile of the vaccine they formulate. Companies are also tying up with government and international organizations to expand their market reach and ensure wider vaccine accessibility.

Some of the most prominent companies in the industry are GlaxoSmithKline plc, Pfizer Inc., Sanofi Pasteur, Merck & Co., Inc., and Novartis AG.

Industry Updates

In April 2024, Nigeria made history by introducing the world’s first 5-in-1 meningitis vaccine, Men5CV. The vaccine, recommended by WHO, aims to combat the deadly disease, with an initial campaign targeting over one million people aged 1-29.
In November 2023, GlobalData reported significant changes in the meningococcal vaccine market with the launch of Pfizer’s Penbraya. The CDC’s Advisory Committee on Immunisation Practices recommended administering Penbraya alongside MenACWY and MenB vaccines for eligible patients aged 10 years and older.
In July 2023, the Serum Institute of India announced that its multivalent meningococcal meningitis vaccine, designed to combat the five predominant strains in Africa, had received WHO prequalification. This approval made the vaccine eligible for procurement by UN agencies and Gavi, the Vaccine Alliance.

Leading Meningococcal Vaccines Brands

GlaxoSmithKline plc
Pfizer Inc.
Sanofi Pasteur
Merck & Co., Inc.
Novartis AG
CSL Limited
Johnson & Johnson
Bharat Biotech International Limited
Serum Institute of India Pvt. Ltd.
Sinovac Biotech Ltd.
Biological E Limited
Chongqing Zhifei Biological Products Co., Ltd.
Beijing Tiantan Biological Products Co., Ltd.
Hualan Biological Engineering Inc.
Walvax Biotechnology Co., Ltd.
Bio-Manguinhos (Fiocruz)
Hangzhou Jinjiang Group Co., Ltd.
Shenzhen Kangtai Biological Products Co., Ltd.
Biomed Pvt. Ltd.
GlaxoSmithKline Biologicals SA

Key Segments of Market Report

On the basis of product type:

The sector is bifurcated into polysaccharides and conjugates.

Based on the age group:

The industry is segmented into infants, children, adolescents, young adults, and adults.

On account of end users:

The sector is segmented into, pharmacies, community, clinics, public health agencies, and others.

As per region:

The industry is divided into North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Track and Trace Solutions Market is set to reach a worth of USD 33.52 Billion by 2033, at a CAGR of 17.8% | Get data by Experts at Future Market Insights, Inc.

The global track and trace solutions market size is anticipated to gain astronomical growth from 2023 to 2033. According to the research report published by FMI, the global market is projected to surpass a valuation of USD 6.51 billion in 2023. It is anticipated to hit a valuation of USD 33.52 billion by 2033. The market is projected to showcase a monumental CAGR of 17.8% from 2023 to 2033.

Tracking and tracing solutions are essential in providing real-time product location data and maintaining a record of the supply chain’s history. The growing emphasis on improving supply chain efficiency is expected to boost the demand for track and trace solutions. This increase in demand is likely to be experienced across various end-use industries, including electrical and electronics, automotive, pharmaceutical, cosmetics, and others.

Asia Pacific is poised to attain rapid growth in the coming years. The increasing population and industrialization across India and China are boosting the demand that effective solutions that track products during their entire lifecycle. China is likely to hold a dominant share of Asia Pacific’s market due to strong retail and e-commerce chains and the presence of prominent electrical and electronic component providers.

The expanding pharmaceutical industry in India is likely to create growth avenues. As a result, many track and trace solution providers are fortifying their capabilities to cater to the growing demand. For instance, DHL Logistics Company aims to launch more than 10,000 cargos with traceability and tracking capabilities in India by 2025.

Europe is anticipated to gain considerable growth during the forecast period. The increasing government regulations are expected to favor market expansion. Additionally, the rising adoption of track and trace solutions in the automobile industry to track cargo supplies, car deliveries, and others are expected to fuel market growth in Europe.

Picture background

Key Takeaways from Track and Trace Solutions Market:

In 2018, the global market size at nearly US$ 2.87 billion.
In 2022, the global market share accounted for US$ 5.53 billion in 2022.
The software segment is anticipated to acquire a prominent market share due to the growing demand for data analytics and business intelligence.
The pharmaceutical segment is anticipated to attain immense due to increasing health complexities across the ever-increasing global population.
The United States is likely to dominate the region due to the presence of prominent companies across various industries, including pharmaceuticals, automobiles, retail and e-commerce, and others.

Recent Developments Observed by FMI:

Systech International Inc. established a partnership with Spherity in August 2022 to offer pharmaceutical solutions with more secure traceability. In accordance with the Drug Supply Chain Security Act, businesses are collaborating to provide quick and simple integrated solutions.
In February 2023, DispatchTrack, a provider of last-mile delivery services, released a new track and trace feature to its last-mile platform. This feature allows for the collection, organization, and presentation of large amounts of data to provide consumers with the precise information they require.

Key Players in the Global Track and Trace Solution Market:

METTLER-TOLEDO, Laetus GmbH, Systech Interntaional Inc., Zebra Technologies Corporation, IBM Corporation, SAP SE, Accenture PLC, Siemens S.A., Honeywell International Inc., HCL Technologies are leading manufacturers of Track and Trace Solutions Market.

Track and Trace Solution Market Segmentation

By Component:

Software
Hardware

By Technology:

Linear Barcode
2D Barcode
Radiofrequency Identification
Others in Track and Trace Solution

By Type:

Serialization
Aggregation

By End-user:

Pharmaceutical
Consumer Durables
Retail and Ecommerce
Automobile
Electrical and Electronics

By Region:

North America Market
Asia Pacific Market
Europe Market
Latin America Market
the Middle East and Africa Market

About Future Market Insights (FMI)

Contact Us:

Gynaecological Examination Chairs Industry to Reach USD 852.3 Million by 2028 at a 6.9% of CAGR, Driven by Rising Awareness of Women’s Health Diagnostics

The global gynaecological examination chairs market is projected to grow significantly, with its valuation increasing from USD 531.6 million in 2021 to USD 852.3 million by 2028, representing a CAGR of 6.9% over the forecast period (2022–2028), according to a recent study by Future Market Insights (FMI).

In 2021, gynaecological examination chairs accounted for approximately 38% of the overall medical examination chairs market, which is valued at $1.4 billion. The growing demand for these specialized chairs is attributed to the increasing global disease burden and heightened awareness about the importance of early detection and diagnostic testing in women’s healthcare.

Gynaecological examination chairs play a pivotal role in diagnosing conditions related to the female reproductive system, including endometrial, cervical, ovarian, and vaginal cancers, as well as menstrual and fertility complications. Their adjustable design allows healthcare professionals to position patients for optimal diagnostic outcomes, improving the accuracy and efficiency of examinations.

Get Complete Full Report – https://www.futuremarketinsights.com/reports/gynaecological-examination-chairs-market

Key Takeaways:

Market Growth: The market is anticipated to grow from USD 531.6 million in 2021 to USD 852.3 million by 2028, with a CAGR of 6.9%.
Significant Market Share: Gynaecological examination chairs constitute 38% of the global medical examination chairs market, valued at USD 1.4 billion.
Increasing Disease Burden: The prevalence of conditions such as cervical and ovarian cancers, fertility issues, and menstrual complications is driving demand for advanced diagnostic solutions.
Enhanced Diagnosis: Adjustable height and position features of gynaecological examination chairs are facilitating better diagnostic outcomes for healthcare providers.

This market’s growth underscores the rising importance of women’s health diagnostics, paving the way for enhanced healthcare solutions and improved patient outcomes globally.

Growth Drivers

Rising Disease Burden: The increasing prevalence of gynecological conditions such as endometrial cancer, cervical cancer, and other reproductive health issues is driving demand for specialized examination chairs.
Awareness of Gynecological Health: Growing awareness about the importance of regular gynecological check-ups and diagnostic tests is encouraging healthcare facilities to invest in advanced examination equipment.
Technological Advancements: Innovations in chair design, including adjustable height and positioning features, enhance comfort and accessibility for both patients and healthcare providers.

Applications

Gynecological examination chairs are essential for various diagnostic procedures related to:

Endometrial cancer
Cervical cancer
Ovarian cancer
Menstrual complications
Vaginal cancer
Fertility complications

These chairs facilitate thorough examinations by allowing healthcare professionals to position patients optimally for accurate diagnostics.

Regional Insights

North America: This region is expected to dominate the market due to high healthcare expenditure and a significant number of gynecological procedures performed in hospitals.
Asia-Pacific: Anticipated to experience substantial growth driven by increasing healthcare investments and rising awareness regarding women’s health issues.

Competitive Landscape

Companies are focusing on marketing and promotional activities through participation in exhibition and trade shows and launch of new product with advanced feature which provide ease in different gynaecological examination and imaging such as Ultrasound and Colposcopy.

Additionally, key players are also focusing on manufacturing of fully electrically operated chairs as there is an increasing demand among medical professionals, thereby, boosting the sale. This can be seen with the following developments in this market:

Schmitz u. Söhne GmbH & Co.KG on 16 July 2021 announced their one-of-a-kind 3D product configurator. Wherein, the buyer can customize any of their product online according their need and functionality.

AGA Sanitaetsartikel GmbH featured its medical furniture product portfolio ranging from operating tables to examination chairs at the Medica 2019 exhibition from November 18 to 21 2019. This display of its product range will definitely help the company in attracting more customers.

Key Companies Profiled

Oakworks Inc.; Hohnhaus & Jansenberger Gruppe GmbH & Co. KG; AGA Sanitaetsartikel GmbH; ATMOS MedizinTechnik GmbH & Co. KG; Favero Health Projects Spa; Schmitz u. Söhne GmbH & Co.KG; Lemi Group; Malvestio Spa; Plinth Medical Ltd; Inmoclinc S.A

Gynaecological Examination Chairs Market by Category

Product:

Non-Electrical
Electrical

Price Range:

Premium
Mid
Low

End User:

Hospitals
Obstetrics & Gynecology Clinics
Others

Region:

North America
Latin America
Western Europe
Eastern Europe
APECJ
China
Japan
Middle East & Africa (MEA)

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Veterinary Molecular Diagnostics Industry to Double by 2033, Reaching USD 377.22 Million with a 6.84% of CAGR, Amid Rising Demand for Advanced Animal Health Solutions

The global veterinary molecular diagnostics market is projected to witness significant growth, with its valuation expected to rise from USD 194.47 million in 2023 to over USD 377.22 million by 2033, reflecting a robust CAGR of 6.84% during the forecast period. This expansion underscores the growing importance of advanced diagnostic solutions in improving animal health outcomes.

The demand for veterinary molecular diagnostics is driven by increasing awareness about zoonotic diseases, rising incidences of infectious diseases in animals, and the growing emphasis on livestock productivity and pet care. These diagnostic tools enable early and precise detection of diseases, facilitating timely intervention and reducing the risk of outbreaks.

Technological advancements in molecular diagnostics, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), are further bolstering the market. These innovations are enhancing the accuracy, speed, and reliability of diagnostic processes, making them indispensable in both clinical and research settings.

A Full Report Overview – https://www.futuremarketinsights.com/reports/veterinary-molecular-diagnostics-market

Key Takeaways:

Market Expansion: The veterinary molecular diagnostics market is expected to grow from USD 194.47 million in 2023 to USD 377.22 million by 2033, at a CAGR of 6.84%.
Zoonotic Disease Awareness: Rising focus on controlling zoonotic and infectious diseases is a key driver for market growth.
Technological Advancements: Innovations such as PCR and NGS are improving the accuracy and efficiency of diagnostics.
Global Impact: Increased investments in veterinary care and the growing adoption of pets worldwide are fueling demand for advanced diagnostic solutions.

The veterinary molecular diagnostics market’s upward trajectory highlights its critical role in advancing animal healthcare and safeguarding global public health.

Key Growth Drivers

Rising Pet Adoption: Increasing pet ownership globally has led to higher healthcare demands for companion animals, driving the need for advanced diagnostic tools.
Increased Animal Health Expenditure: As pet owners treat their animals as family members, there is a corresponding rise in spending on veterinary care, including molecular diagnostics.
Growing Livestock Population: The demand for animal-derived products is contributing to an increase in the livestock population, which in turn drives the need for effective diagnostic tests to ensure animal health.
Technological Advancements: Innovations in molecular diagnostic technologies are enhancing the accuracy and efficiency of disease detection in animals, making these tools more appealing to veterinary practices.
Awareness of Animal Wellness: There is a growing emphasis on animal welfare and health, prompting veterinarians and pet owners to adopt advanced diagnostic modalities.

Key Companies Profiled

bioMérieux SA
IDEXX Laboratories, Inc.
Neogen Europe, Ltd.
Veterinary Molecular Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
ID-Vet, Qiagen N.V.

Key Segments Covered in the Veterinary Molecular Diagnostics Industry Analysis

By Product Type:

PCR Kits
- RT-PCR Kits
- RAPD-PCR Kits
INAAT Kits
Microarray Kits
DNA Sequencing Kits

By Species Type:

Livestock Animals
- Equine
- Porcine
- Poultry
- Cattle
- Aquatic
- Ovine
Companion Animals
- Canine
- Feline
- Avian

By Disease Type:

Anaplasma spp.
Ehrlichia spp.
New Castle Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others

By End User:

Veterinary Hospitals
Clinical Laboratories
Veterinary Research Institutes

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ultrasound Systems Industry to Reach USD 13.2 Billion by 2028 at a 5.5% of CAGR, Bolstered by Advances in Imaging Technology and Rising Disease Burden

The global ultrasound systems market, valued at USD 9.5 billion in 2022, is projected to grow at a CAGR of 5.5% to reach USD 13.2 billion by 2028. The market’s robust growth is attributed to advancements in imaging technologies, the rising global disease burden, and expanded applications of ultrasound systems in early diagnosis and treatment planning.

Over the past two decades, ultrasound imaging techniques have seen significant evolution, with innovations in engineering methods aimed at overcoming traditional challenges such as data loss, poor image resolution, and limited uniformity. These advancements are driving the adoption of next-generation ultrasound systems in diagnostic and therapeutic applications across the healthcare sector.

The market is also benefiting from the increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions. Ultrasound systems are playing a pivotal role in the early detection and management of these conditions, enabling timely interventions and improving patient outcomes. Additionally, government initiatives aimed at reducing maternal and infant mortality through awareness programs are further fueling demand for ultrasound imaging, especially in prenatal care and disease prevention.

Full Report Revealed – https://www.futuremarketinsights.com/reports/ultrasound-systems-market

Key Takeaways:

Market Growth: The ultrasound systems market is anticipated to grow from USD 9.5 billion in 2022 to USD 13.2 billion by 2028, at a CAGR of 5.5%.
Technological Advancements: Innovations in imaging architecture are addressing limitations in data accuracy, resolution, and uniformity.
Chronic Disease Focus: Rising cases of cancer, cardiovascular, and neurodegenerative disorders are driving adoption for early diagnosis and treatment planning.
Global Health Initiatives: Collaborative efforts by governments to combat maternal and infant mortality are contributing to market expansion.

The ultrasound systems market is positioned for sustained growth, propelled by technological advancements and its critical role in shaping the future of diagnostic imaging and patient care.

Growth Drivers

Technological Advancements: Continuous improvements in ultrasound imaging techniques, including enhanced resolution and reduced data loss, are making these systems more effective and reliable for diagnostic purposes.
Rising Incidence of Chronic Diseases: The growing prevalence of chronic conditions such as cancer, cardiovascular disorders, and neurodegenerative diseases is increasing the demand for ultrasound systems for early diagnosis and management.
Importance in Maternal and Infant Care: Ultrasound plays a crucial role in monitoring pregnancy and fetal development, contributing to efforts aimed at reducing maternal and infant mortality rates through increased awareness and accessibility.
Non-Invasive Nature of Ultrasound: The non-invasive characteristics of ultrasound imaging make it a preferred choice for many diagnostic applications, further propelling its adoption.

Regional Insights

North America is expected to hold a significant share of the market due to advanced healthcare infrastructure and high healthcare spending.
The Asia-Pacific region is anticipated to witness substantial growth driven by increasing healthcare investments and rising patient populations requiring diagnostic services.

Competitive Landscape

Key players in the ultrasound systems market utilize strategies involving production and development of revised product portfolio and new product launch, industry expansions aimed at enhancing their business operations and existing services, acquisitions of major health businesses to rapidly grow their core offerings, and making distribution agreements with branded pharmaceutical manufacturers to engage larger consumer base.

In September 2021, GE Healthcare confirmed plans to acquire ultrasound innovator BK Medical to boost its precision health presence globally.
In January 2020, Siemens Healthineers India launched ACUSON Redwood Ultrasound System at Indian Radiological & Imaging Association (IRIA). The system is built on the company’s new platform architecture and features advanced applications for greater clinical confidence, AI-powered tools for smart workflows and has shared services cardiology features used by different hospital departments.

Similarly, recent developments related to companies manufacturing ultrasound systems market services and technologies have been tracked by the team at Future Market Insights, which are available in the full report.

Key Companies Profiled

GE Company; Fujifilm Holdings Corporation; Siemens AG; Koninklijke Philips N.V.; Toshiba Medical System Corp.; Hitachi Medical Corp.; Mindray Medical International Ltd; FUJIFILM Holdings Corporation; Samsung Medison Co., Ltd; Esaote SpA; Others

Key Market Segments Covered in Ultrasound systems Market Research

By Modality:

Cart/Trolley Based
Compact/Hand Held

By Application:

Radiology
Obstetrics & Gynaecology
Cardiology
Gastroenterology
Others

By End User:

Hospitals & Clinics
Diagnostic Imaging & Surgical Centers
ASCs
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
MEA

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global IP Camera Market demand to soar at USD 31.3 Billion by 2033 amid Rising Incidence of Home Burglaries and Squatting Worldwide | Future Market Insights, Inc.

In 2033, size of the worldwide IP camera market is anticipated to reach USD 31.3 billion. In 2023, it was valued at over USD 12.8 billion. From 2023 to 2033, a CAGR of 9.4% is anticipated.

Due to increasing home burglaries and squatters, security cameras are becoming more and more important. Today, home security is regarded as one of the top worries for homeowners.

Over the next ten years, it is projected that this factor will fuel growth in the IP camera industry. As urban populations have increased, residential surveillance has become more common.

Launch of new products is one of the most important strategies for leading companies. Trustworthy businesses are increasing their investments in networking, camera technology, product engagement, and ongoing research & development.

IoT technologies are becoming more popular among homeowners, which will foster market expansion. To increase the safety of their homes, people are mainly shifting toward smart IP cameras over traditional Wi-Fi devices. Those who work in the IP camera sector will gain from this by broadening their presence.

Demand for IP cameras has greatly increased as a result of the launch of infrared cameras, as well as expanding IoT use in video surveillance. Demand for privacy in residential settings, soaring use in business buildings, and expanding support for smart homes are all predicted to enhance IP camera sales. Growing use of smartphones and accessibility of alluring security system payment choices are further pushing the residential industry.

A computer network that is based on an active Wi-Fi and web network can be combined with other systems using that network. Compared to an analogue system, an IP surveillance camera CCTV has a number of benefits.

Using IP security cameras with a range of features and technologies, users can record video in HD, handle changing lighting conditions during the day, and occasionally & remotely focus their camera. A few examples of advanced camera characteristics are frames per second, image sensors, camera iris, HD analogue technology, remote focus lenses, PTZ technology, video compression, and HD resolution.

Key Takeaways from IP Camera Market Study:

The global IP camera market exhibited a CAGR of around 1% in the historical period between 2018 and 2022.
Asia Pacific IP camera market size was US$ 5.6 billion in 2022.
The USA IP camera market is expected to be worth US$ 5.2 billion by 2033.
Japan IP camera market is expected to create an incremental dollar growth of US$ 3.0 billion till 2033.
Based on component, the hardware segment is expected to surge at a CAGR of 2% from 2023 to 2033.

“IP cameras are used in both residential and commercial applications for security and monitoring. Electronic video cameras known as IP cameras are able to transmit and receive visual data via an IP network.” – Says a lead analyst.

Competitive Landscape: IP Camera Market

Reputable IP camera manufacturers are focusing on delivering cutting-edge goods and services. They might enhance sales and earnings while also broadening their consumer base.

For instance, in September 2022 Sony Electronics Inc. released the ILME-FR7. It has a built-in pan, tilt, and zoom feature, a full-frame image sensor, and an interchangeable e-mount lens. Its cinematic features and programmable remote control would open up new exciting potential in live recording, theater, and movie scenarios.

For instance,

In August 2022, Clipsal by Schneider Electric unveiled outdoor and indoor security cameras under its new range, Wiser. The Wiser Smart Home Security solution is currently available in Australia. It would enable builders and electricians to add to their integrating and security offering.

Get More Exclusive Insights into IP Camera Market Study

Future Market Insights (FMI), in its new offering, presents an unbiased analysis of the IP camera market, presenting historical market data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.

The study reveals extensive growth in the IP camera market in terms of component (hardware, services), product type (fixed, pan-tilt-zoom, infrared), connection (consolidated, distributed), application (residential, commercial, government), and region.

IP Camera Market Outlook by Category

By Component:

Hardware
Services

By Product Type:

Fixed
Pan-Tilt-Zoom
Infrared

By Connection:

Consolidated
Distributed

By Application:

Residential
Commercial
Government

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Gait Trainer Industry to Reach USD 456.3 Million by 2028 at a 4.9% CAGR, Driven by Rising Demand for Cerebral Palsy Rehabilitation Solutions

The global gait trainer market is projected to grow at a CAGR of 4.9% during the forecast period, with its valuation increasing from USD 342.7 million in 2022 to an estimated USD 456.3 million by 2028, according to the latest analysis by Future Market Insights. This growth is attributed to the increasing prevalence of cerebral palsy and heightened demand for advanced rehabilitation solutions.

In 2021, the global exoskeleton market was valued at USD 4.1 billion, with gait trainer sales accounting for 8% of the total. Gait trainer walkers, particularly those designed for individuals with cerebral palsy, have gained significant traction in recent years as awareness around specialized rehabilitation devices continues to grow. These devices are pivotal in enhancing mobility and improving quality of life for individuals with neuromuscular conditions.

The market’s progression is further bolstered by advancements in assistive technology, including innovative designs that ensure greater stability, adaptability, and user comfort. As healthcare systems across the globe prioritize inclusive care for mobility-impaired individuals, the adoption of gait trainers is expected to grow, particularly in pediatric and geriatric populations.

A Full Report Analysis – https://www.futuremarketinsights.com/reports/gait-trainer-market

Key Takeaways:

Modest Growth: The gait trainer market is anticipated to expand from USD 342.7 million in 2022 to USD 456.3 million by 2028, at a CAGR of 4.9%.
Cerebral Palsy Focus: Increasing cases of cerebral palsy have driven demand for specialized gait trainer walkers.
Exoskeleton Synergy: Gait trainers accounted for 8% of the USD 4.1 billion exoskeleton market in 2021, indicating their growing importance in the broader mobility assistance landscape.
Technology Advancements: Innovations in stability, adaptability, and comfort are fueling market adoption, particularly in pediatric and geriatric rehabilitation.

The gait trainer market is set to play a crucial role in enhancing rehabilitation outcomes, paving the way for a more inclusive approach to mobility assistance worldwide.

Growth Drivers

Rising Incidence of Cerebral Palsy: There has been a significant increase in the incidence of cerebral palsy, leading to greater demand for gait trainer walkers specifically designed for affected individuals.
Aging Population: The increasing geriatric population, which is more prone to mobility issues, is driving demand for gait trainers as these devices assist in rehabilitation and improve mobility.
Technological Advancements: Innovations in gait training technology, including the development of robotic and customizable gait trainers, are enhancing the effectiveness and appeal of these devices.
Increased Awareness and Adoption: Growing awareness about the benefits of gait trainers in rehabilitation settings is contributing to their increased adoption among healthcare providers and patients.

Gait Trainer Market Competitive Landscape

Gait trainer manufacturers are focusing on developing new and affordable products that would cater to a larger customer base. The manufacturers of gait trainers are also focusing on reducing the costs and complexities associated with the use of gait trainers. As demand for automated gait trainers ramps up, manufacturers are expected to launch new products to boost their sales across the world.

In March 2021, the USA FDA (Food and Drug Administration) announced the authorization of marketing of a new device that would aid in the treatment of multiple sclerosis (MS) which is a very common neurological disease among young adults. The Portable Neuromodulation Stimulator (PoNS) device would be a short-term treatment for gait deficit which is a result of mild symptoms of the aforementioned MS.
In May 2021, Ekso Bionics Holdings Inc., an industry-leading name in the medical exoskeleton technology industry announced the expansion of its partnership with Kindred Healthcare LLC. Through this expansion of partnership, Ekso brings Kindred’s EskoNR to four major hospitals in the U.S.

Key Companies Profiled

Meyland Smith A/S; Biodex Medical Systems; medica Medizintechnik GmbH; ReWalk Robotics; Alter G Inc.; Rex Bionics Ltd.; Ekso Bionics; Hocoma AG; Otto Bock Inc.; Rifton Equipment; Medical Depot Inc. (Drive Medical)

Key Segments Covered in Gait Trainer Industry Survey

Gait Trainer Market by Product Type:

Gait Trainer Walkers
- Adult
- Pediatric
Exoskeletons
Treadmill Systems

Gait Trainer Market by End User:

Gait Trainers for Hospitals
Gait Trainers for Rehabilitation Centers
Gait Trainers for Home Care Settings

Gait Trainer Market by Region:

North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa (MEA)

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube